Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia

Status:
Completed

Trial end date:
2005-01-01

Target enrollment:

Participant gender:

The purpose of this trial is to determine if paliperidone ER is an effective treatment for adults with schizophrenia.

Phase 3

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Paliperidone Palmitate